Molecular characterization of AML with RUNX1-RUNX1T1 at diagnosis and relapse reveals net loss of co-mutations

AML with RUNX1-RUNX1T1 fusion is a WHO entity with a favorable outcome following intensive chemotherapy. The absence of RUNX1-RUNX1T1 transcripts in remission defines complete molecular response and correlates with a superior survival. However, a significant proportion of patients still relapses and...

Full description

Saved in:
Bibliographic Details
Published in:Hemasphere
Main Authors: Höllein, Alexander, Nadarajah, Niroshan, Meggendorfer, Manja, Jeromin, Sabine, Kern, Wolfgang, Haferlach, Claudia, Haferlach, Torsten
Format: Artigo
Language:Inglês
Published: Wolters Kluwer Health 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745937/
https://ncbi.nlm.nih.gov/pubmed/31723813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000178
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items